Cargando…
Nanocurcumin Modulates miR-223-3p and NF-κB Levels in the Pancreas of Rat Model of Polycystic Ovary Syndrome to Attenuate Autophagy Flare, Insulin Resistance and Improve ß Cell Mass
PURPOSE: Polycystic ovary syndrome (PCOS) is a prevalent female endocrine disorder. 50–70% of PCOS patients suffer from glucose intolerance, insulin and β cell impairments. Updated studies reveal the crucial regulatory role of inflammation modulators in various diseases, by manipulating autophagy an...
Autores principales: | Abuelezz, Nermeen Z, E Shabana, Marwa, Rashed, Laila, NB Morcos, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405883/ https://www.ncbi.nlm.nih.gov/pubmed/34475786 http://dx.doi.org/10.2147/JEP.S323962 |
Ejemplares similares
-
Decreased Serum Level of Gamma-amino Butyric Acid in Egyptian Infertile Females with Polycystic Ovary Syndrome is Correlated with Dyslipidemia, Total Testosterone and 25(OH) Vitamin D Levels
por: Radwan, Rasha A., et al.
Publicado: (2019) -
MON-223 Adipose Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome
por: Hoyos, Luis, et al.
Publicado: (2019) -
The theranostic potentialities of bioavailable nanocurcumin in oral cancer management
por: Essawy, Marwa M., et al.
Publicado: (2022) -
The Involvement of Canonical NFκB Pathway in Megakaryocyte Differentiation Induction by Nanocurcumin
por: Mortazavi Farsani, Seyedeh Sahar, et al.
Publicado: (2023) -
Significant Role of Dicer and miR-223 in Adipose Tissue of Polycystic Ovary Syndrome Patients
por: Qin, Lang, et al.
Publicado: (2019)